cell

In allogeneic stem cell transplantation (ASCT), antibiotic treatment of neutropenic and organ infections is widely used and needed: Blood stream infections (BSI) account for the most severe manifestations and occur …

Contra Costa County Supervisor John Gioia with his son, Chris at past Coastal Cleanup in Richmond, and with Chris’ mother Maria “Charo” Gioia at the Stanford Medical Center housing. Photos …

{{cta-block}} Milestones are more than metaphors to Arthur Yu, a marathon runner with an impressive weightlifting habit. As dad to 2-year-old Abel, he’s charted them in first steps, first teeth …

NatureReal-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphomaPrior to the advent of chimeric antigen receptor (CAR) T-cell therapy, patients with relapsed/refractory (R/R) mantle cell …

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory decision …

Trainees in hematology, hematopoietic cell transplantation (HCT), and cellular therapy (CT) face complex patient care scenarios that require advanced skills in symptom management, communication, and shared decision-making. However, many report …

An emotional appeal on VRT’s annual radio and television charity drive De Warmste Week (The Warmest Week) has sparked an unprecedented surge in potential stem cell donors for 11-year-old Hafsa …

Highlights First documentation of continuing disparities since new standard of care beganTeam calls for more precise donor selectionInternational conference continues today in Orlando, Florida Newswise — BUFFALO, N.Y. — A …

By: Monica Smith | December 08, 2025 | 7 min. read | Share Summary A Sylvester Comprehensive Cancer Center study reveals patients can safely receive stem cell transplants from unrelated …

Allogeneic hematopoietic stem cell transplantation (HSCT) is considered standard of care in eligible patients with acute myeloid leukemia (AML) and intermediate or adverse risk in first complete remission (CR) as …